Dr. Neil Michael Barth MD Medical Oncologist

Dr. Neil Barth is a medical oncologist in Irvine, California and is affiliated with Hoag Memorial Hospital Presbyterian. He received his medical degree from University of Toledo College of Medicine and has been in practice for 37 years. Dr. Barth accepts several types of health insurance, listed below. He is one of 12 doctors at Hoag Memorial Hospital Presbyterian who specialize in Medical Oncology.

Are you Dr. Barth? Edit Profile

Office Location

See Contact Information

Specialty & Clinical Interests

Medical Oncologist: General Oncology, Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Gastrointestinal Cancer

Clinical Interests: Cancer Genetics, Immunotherapy, Cancer Vaccines, Melanoma, Treatment Outcome, Survival Rate, Retrospective Studies, Interleukin-2, Neoplasm Metastasis, Immunotherapy

Hospital Affiliation

Hoag Memorial Hospital Presbyterian
High performing in Cancer

Education & Medical Training

Los Angeles County-Harbor-UCLA Medical Center
Residency, Internal Medicine, 1978–1980

Los Angeles County-Harbor-UCLA Medical Center
Fellowship, Hematology, 1980–1981

Los Angeles County-Harbor-UCLA Medical Center
Fellowship, Medical Oncology, 1981–1983

Los Angeles County-Harbor-UCLA Medical Center
Internship, Transitional Year, 1977–1978

University of Toledo College of Medicine
Class of 1977

Certifications & Licensure

American Board of Internal Medicine
Certified 34 years in Internal Medicine

American Board of Internal Medicine
Certified 32 years in Hematology

American Board of Internal Medicine
Certified 31 years in Medical Oncology

CA State Medical License
Active through 2015

Awards, Honors & Recognition

Meaningful Use Stage 1 Certification, Centers for Medicare & Medicaid Services

Super Doctor, SuperDoctors.com

Most Compassionate Doctor, American Registry

Top MD, Consumers Checkbook

Publications & Presentations

Should high-dose interleukin-2 still be the preferred treatment for patients with metastatic melanoma?
Dillman, R. O., Barth, N. M., Vandermolen, L. A., Mahdavi, K., McClure, S. E.

Should High-Dose Interleukin-2 Still be the Preferred Treatment for Patients with Metastatic Renal Cell Cancer?
Dillman, R.O., Barth, N.M., Vandermolen, L.A., Fong, W.H., Mahdavi, K.K., McClure, S.E.

Phase II trial of dendritic cells loaded with antigens from self-renewing, proliferating autologous tumor cells as patient-specific antitumor vaccines in patients with metastatic melanoma: final report.
Dillman, R.O., Selvan, S.R., Schiltz, P.M., McClay, E.F., Barth, N.M., DePriest, C., de Leon, C., Mayorga, C., Cornforth, A.N., Allen, K.

See all 31 publications

Insurances Accepted

  • Aetna Choice POS II
  • BCBS Blue Card PPO
  • BCBS California PPO
  • Blue Shield California PPO
  • CIGNA Open Access
  • First Health PPO
  • Great West PPO
  • Health Net California Large Group PPO
  • Humana ChoiceCare Network PPO
  • Multiplan PHCS PPO
  • Multiplan PHCS PPO - Kaiser
  • Multiplan PPO
  • United Healthcare - Direct Choice Plus POS
  • United Healthcare - Direct Options PPO

Report a Correction — If you are aware of information on this page that is out of date or incorrect, please let us know.

Patient Advice & Support

See More
Our Doctor Finder includes most U.S. physicians. Doctors are not ranked, learn more.

Nearby Medical Oncologists

See all Medical Oncologists near Irvine, CA See all Medical Oncologists in California

Your Message Has Been Submitted

As part of our research on the correction you submitted, you may be contacted at the email address provided.

Sorry, Your Message Could Not Be Submitted

Please try again later, or E-mail your message to doctors@usnews.com and include the Web address (URL) of the page that contains incorrect information.